JP2008507547A5 - - Google Patents

Download PDF

Info

Publication number
JP2008507547A5
JP2008507547A5 JP2007522763A JP2007522763A JP2008507547A5 JP 2008507547 A5 JP2008507547 A5 JP 2008507547A5 JP 2007522763 A JP2007522763 A JP 2007522763A JP 2007522763 A JP2007522763 A JP 2007522763A JP 2008507547 A5 JP2008507547 A5 JP 2008507547A5
Authority
JP
Japan
Prior art keywords
alkyl
purine
yield
methyl
scheme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007522763A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008507547A (ja
JP5078612B2 (ja
JP2008507547A6 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/025916 external-priority patent/WO2006012440A2/en
Publication of JP2008507547A publication Critical patent/JP2008507547A/ja
Publication of JP2008507547A5 publication Critical patent/JP2008507547A5/ja
Publication of JP2008507547A6 publication Critical patent/JP2008507547A6/ja
Application granted granted Critical
Publication of JP5078612B2 publication Critical patent/JP5078612B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007522763A 2004-07-21 2005-07-21 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製 Expired - Lifetime JP5078612B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58986604P 2004-07-21 2004-07-21
US60/589,866 2004-07-21
US60823004P 2004-09-09 2004-09-09
US60/608,230 2004-09-09
PCT/US2005/025916 WO2006012440A2 (en) 2004-07-21 2005-07-21 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011061926A Division JP5351919B2 (ja) 2004-07-21 2011-03-22 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製

Publications (4)

Publication Number Publication Date
JP2008507547A JP2008507547A (ja) 2008-03-13
JP2008507547A5 true JP2008507547A5 (https=) 2011-07-14
JP2008507547A6 JP2008507547A6 (ja) 2011-09-01
JP5078612B2 JP5078612B2 (ja) 2012-11-21

Family

ID=35786706

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007522763A Expired - Lifetime JP5078612B2 (ja) 2004-07-21 2005-07-21 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製
JP2011061926A Expired - Lifetime JP5351919B2 (ja) 2004-07-21 2011-03-22 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011061926A Expired - Lifetime JP5351919B2 (ja) 2004-07-21 2011-03-22 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製

Country Status (16)

Country Link
EP (2) EP2348029A1 (https=)
JP (2) JP5078612B2 (https=)
KR (2) KR101236669B1 (https=)
CN (1) CN102199181B (https=)
AT (1) ATE543789T1 (https=)
AU (2) AU2005267051B2 (https=)
CA (2) CA2574651C (https=)
DK (1) DK1773856T3 (https=)
ES (1) ES2386005T3 (https=)
IL (2) IL180832A (https=)
MX (1) MX2007000803A (https=)
NZ (1) NZ552927A (https=)
PL (1) PL1773856T3 (https=)
PT (1) PT1773856E (https=)
RU (1) RU2407747C2 (https=)
WO (1) WO2006012440A2 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EP1736478B1 (en) 2000-05-26 2015-07-22 IDENIX Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN1678326A (zh) 2002-06-28 2005-10-05 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2'-c-甲基-3'-o-l-缬氨酸酯核糖呋喃基胞苷
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
LT1576138T (lt) 2002-11-15 2017-06-26 Idenix Pharmaceuticals Llc 2`-šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija
AU2003300901A1 (en) 2002-12-12 2004-06-30 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
HUE029877T2 (en) 2003-05-30 2017-04-28 Gilead Pharmasset Llc Modified fluorinated nucleoside analogues
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
US8492539B2 (en) * 2004-09-14 2013-07-23 Gilead Pharmasset Llc Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
KR101057239B1 (ko) * 2006-10-10 2011-08-16 에프. 호프만-라 로슈 아게 뉴클레오사이드 리보푸라노실 피리미딘의 제조
ATE542810T1 (de) * 2006-12-18 2012-02-15 Hoffmann La Roche Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton
US20080261913A1 (en) 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
WO2008090046A1 (en) * 2007-01-23 2008-07-31 F. Hoffmann-La Roche Ag Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
NZ593649A (en) 2008-12-23 2013-11-29 Gilead Pharmasset Llc Nucleoside analogs
AU2009329872B2 (en) * 2008-12-23 2016-07-07 Gilead Pharmasset Llc Synthesis of purine nucleosides
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
SG184324A1 (en) 2010-03-31 2012-11-29 Gilead Pharmasset Llc Nucleoside phosphoramidates
JP5716500B2 (ja) 2010-06-03 2015-05-13 セントラル硝子株式会社 (2R)−2−フルオロ−2−C−メチル−D−リボノ−γ−ラクトン類前駆体の製造方法
CA2818853A1 (en) 2010-11-30 2012-06-07 Gilead Pharmasset Llc 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
US8877733B2 (en) 2011-04-13 2014-11-04 Gilead Sciences, Inc. 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
EP2709613B2 (en) 2011-09-16 2020-08-12 Gilead Pharmasset LLC Methods for treating hcv
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
EP2950786B1 (en) 2013-01-31 2019-11-27 Gilead Pharmasset LLC Combination formulation of two antiviral compounds
JP6394588B2 (ja) * 2013-02-28 2018-09-26 セントラル硝子株式会社 (2R)−2−フルオロ−2−C−メチル−D−リボノ−γ−ラクトンの製造方法
JP6476591B2 (ja) * 2013-06-05 2019-03-06 セントラル硝子株式会社 (2R)−2−フルオロ−2−C−メチル−D−リボノ−γ−ラクトン類の製造方法
PT3038601T (pt) 2013-08-27 2020-06-30 Gilead Pharmasset Llc Formulação combinada de dois compostos antivirais
WO2015097605A1 (en) * 2013-12-23 2015-07-02 Mylan Laboratories Ltd. Process for the preparation of sofosbuvir
WO2016035006A1 (en) * 2014-09-01 2016-03-10 Dr. Reddy’S Laboratories Limited Novel nucleotide analogs, process for the preparation of sofosbuvir and its analogs, novel forms of sofosbuvir and solid dispersion of sofosbuvir
WO2016042576A1 (en) 2014-09-16 2016-03-24 Cadila Healthcare Limited Co-crystal of sofosbuvir and amino acid and process for preparation thereof
CN104327138B (zh) * 2014-10-21 2017-05-10 齐鲁制药有限公司 Psi‑7977中间体化合物的制备方法
USD791845S1 (en) 2015-09-22 2017-07-11 Samsung Electronics Co., Ltd. Door guard for refrigerator
USD791200S1 (en) 2015-09-24 2017-07-04 Samsung Electronics Co., Ltd. Door guard for refrigerator
US10239910B2 (en) 2016-07-20 2019-03-26 Optimus Drugs (P) Limited Process for the preparation of sofosbuvir
CN109422710B (zh) * 2017-08-28 2022-06-21 常州制药厂有限公司 一种索非布韦氟内酯中间体的制备方法
CN111362989B (zh) * 2020-03-19 2022-03-08 江苏工程职业技术学院 一种索非布韦关键中间体的制备方法
WO2021202669A2 (en) 2020-04-01 2021-10-07 Reyoung Corporation Nucleoside and nucleotide conjugate compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
YU25500A (sh) * 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
US6462191B1 (en) * 2000-07-13 2002-10-08 Air Products And Chemicals, Inc. Synthesis of 2-deoxy-2-fluoro-arabinose derivatives
SK286630B6 (sk) * 2001-01-22 2009-02-05 Merck & Co., Inc. Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
EP1556399A4 (en) * 2002-07-16 2007-09-26 Merck & Co Inc Nucleoside derivatives as inhibitors of RNA-dependent viral RNA polymerase
HUE029877T2 (en) * 2003-05-30 2017-04-28 Gilead Pharmasset Llc Modified fluorinated nucleoside analogues

Similar Documents

Publication Publication Date Title
JP2008507547A5 (https=)
US6927291B2 (en) Method for the synthesis of 2′,3′-dideoxy-2′,3′-didehydronucleosides
AU2002255654A1 (en) Method for the synthesis of 2',3'-dideoxy -2',3'-didehydronucleosides
IL106071A (en) Stereoselective glycosylation process for preparing beta-anomer enriched 2'-deoxy-2'-fluoro (and 2',2'-difluoro)-ribofuranosyl nucleosides
JPH06192255A (ja) オキセタニルプリン及びピリミジン類縁体
JPH0673086A (ja) 立体選択的な陰イオングリコシル化法
JP4430307B2 (ja) 2’−ハロ−β−L−アラビノフラノシルヌクレオシドの製造方法
AU2002303187A1 (en) Process for the preparation of 2'-HALO-Beta-L-arabinofuranosyl nucleosides
US5466787A (en) Process for preparing AZT
US20060173174A1 (en) Difluoronucleosides and process for preparation thereof
Jung et al. Synthesis and biological activity of a series of methylene-expanded oxetanocin nucleoside analogues
JP4383126B2 (ja) 4’−c−エチニル−2’−デオキシプリンヌクレオシドの製造法
JPH01224390A (ja) ヌクレオシド誘導体の製造方法
JPH01104092A (ja) ヌクレオシド誘導体
HK1117169B (en) PROCESS FOR THE PREPARATION OF 2'-HALO-β-L-ARABINOFURANOSYL NUCLEOSIDES
JPH0778044B2 (ja) フルオロシクロペンタン誘導体およびその製法
JP2008110983A (ja) 4’−c−エチニルヌクレオシド化合物
HK1130670B (en) Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substitued ribofuranosyl pyrimidines and purines and their derivatives